sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2381 |
4. Check minimum number of eventsNone |
2381 |
5. Include endpointsNone |
2381 |
6. Filter based on genotype QC (FinnGen only) |
2381 |
Control definitions (FinnGen only)
- Control exclude
- K11_GALLBILPANC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K83
- Name in latin
- Cholangitis
Similar endpoints
↥List of similar endpoints to
Cholangitis (primary sclerosing, PSC)
based on the number of shared cases.
Similar with more cases:
- Disorders of gallbladder, biliary tract and pancreas
- Gastrointestinal diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17623 | 8929 | 8513 |
| Only index persons | 14119 | 7308 | 6811 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.26 | 0.24 |
| Only index persons | 0.26 | 0.27 | 0.26 |
| Median age at first event (years) | |||
| Whole population | 69.88 | 71.11 | 68.55 |
| Only index persons | 69.40 | 70.72 | 67.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2381 | 1129 | 1252 |
| Unadjusted period prevalence (%) | 0.47 | 0.38 | 0.55 |
| Median age at first event (years) | 63.25 | 60.05 | 66.14 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2140
- Matched controls
- 21400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
542.9
323.0
401
9
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
867.1
323.0
705
12
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
+∞
323.0
313
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
123.9
323.0
419
42
A05AA02
ATC
ursodeoxycholic acid; oral
198.0
323.0
678
50
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
399.8
323.0
467
15
K83.1
ICD-10 Finland
Obstruction of bile duct
+∞
323.0
446
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
599.1
323.0
543
12
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
297.3
323.0
519
23
K83.0
ICD-10 Finland
Cholangitis
+∞
323.0
2065
*
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2547.3
323.0
389
*
UJK02
NOMESCO Finland
ERCP
484.0
323.0
774
25
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
18.1
323.0
743
609
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3215.5
308.8
291
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
39.1
296.5
379
117
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
37.9
286.5
369
117
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
17.1
278.5
462
338
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
318.4
278.2
277
10
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
+∞
254.3
239
*
K51.5
ICD-10 Finland
Left sided colitis
26.7
254.2
359
160
A07EC02
ATC
mesalazine; oral, rectal
13.2
252.8
471
447
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.1
250.0
706
1378
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
48.2
238.9
292
70
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.6
217.7
1025
3541
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
19.6
205.6
321
191
J01MA12
ATC
levofloxacin; systemic
5.1
203.1
799
2253
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.4
201.6
534
916
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.3
196.3
602
1258
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
49.5
195.7
238
54
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.1
190.7
1061
4144
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
+∞
188.3
178
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
95.5
188.1
207
24
UJF30
NOMESCO Finland
Ileoscopy through colon
7.0
182.3
501
894
R10.1
ICD-10 Finland
Pain localized to upper abdomen
5.5
176.8
603
1413
A09AA02
ATC
multienzymes (lipase, protease etc.)
50.5
176.7
214
47
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
+∞
176.5
167
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
862.2
165.0
160
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
+∞
163.7
155
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
850.5
162.8
158
*
JN3AD
NOMESCO Finland
Abdominal CT examination
8.1
162.0
395
582
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
+∞
160.4
152
*
JKA20
NOMESCO Finland
Cholecystectomy
66.9
159.4
184
30
L04AX01
ATC
azathioprine; systemic
10.4
157.8
328
367
UJF32
NOMESCO Finland
Coloscopy
3.8
155.2
863
3214
K81.0
ICD-10 Finland
Acute cholecystitis
336.8
154.9
155
5
WX402
NOMESCO Finland
General anaesthesia
4.6
150.0
618
1737
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
180.3
145.5
151
9
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.9
140.4
709
2388
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
1381.9
134.9
130
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
37.3
133.6
172
50
R50.9
ICD-10 Finland
Fever, unspecified
4.4
131.9
568
1639
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
18.0
126.6
202
123
K85
ICD-10 Finland
Acute pancreatitis
431.7
124.1
123
*
K51.8
ICD-10 Finland
Other ulcerative colitis
29.5
123.9
169
62
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
328.7
122.6
123
*
Z94.4
ICD-10 Finland
Liver transplant status
115.2
120.5
130
12
K80.1
ICD-10 Finland
Calculus of gallbladder with other cholecystitis
+∞
119.9
114
*
J01MA02
ATC
ciprofloxacin; systemic
3.0
119.5
1099
5628
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
118.9
690
2545
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
10.4
118.2
242
258
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
33.3
112.8
149
48
JLC30
NOMESCO Finland
Pancreatoduodenectomy
163.9
104.2
109
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
103.6
444
1243
A07EA06
ATC
budesonide; oral, local oral
9.4
102.6
222
260
JJC00
NOMESCO Finland
Allogenic transplantation of liver
185.7
102.3
106
6
WX002
NOMESCO Finland
Sedation and analgesia
3.3
100.1
621
2358
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
97.7
1131
6379
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.8
97.4
219
273
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
38.3
96.3
123
34
127
Kela drug reimbursment
Transplant complication
17.5
91.5
147
90
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
466.9
90.9
90
*
K86.1
ICD-10 Finland
Other chronic pancreatitis
+∞
90.2
86
*
K80.4
ICD-10 Finland
Calculus of bile duct with cholecystitis
+∞
89.2
85
*
P01AB01
ATC
metronidazole; oral, rectal
2.6
88.9
957
5085
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.5
87.9
243
412
K85.8
ICD-10 Finland
Other acute pancreatitis
883.1
87.3
85
*
K76.9
ICD-10 Finland
Liver disease, unspecified
17.8
85.5
136
81
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
31.6
85.4
114
38
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
83.2
718
3324
K74.3
ICD-10 Finland
Primary biliary cirrhosis
54.5
83.1
99
19
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.3
81.9
269
563
K85.1
ICD-10 Finland
Biliary acute pancreatitis
+∞
80.7
77
*
K81.9
ICD-10 Finland
Cholecystitis, unspecified
+∞
80.7
77
*
130
Kela drug reimbursment
Malignant tumour
4.3
79.7
330
878
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
41.5
79.0
99
25
A02BC02
ATC
pantoprazole; systemic
2.4
78.6
1451
9968
N02AA05
ATC
oxycodone; systemic
3.2
77.4
483
1793
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
266.3
75.9
77
*
K50.8
ICD-10 Finland
Other Crohn disease
15.9
75.8
126
84
K80.8
ICD-10 Finland
Other cholelithiasis
60.4
74.3
87
15
N02AX02
ATC
tramadol; systemic, rectal
2.3
73.1
1005
5878
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
29.6
73.1
99
35
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
114.0
71.3
77
7
L04AD01
ATC
ciclosporin; systemic
11.5
69.2
133
123
JN4CD
NOMESCO Finland
Very extensive body CT
6.5
69.1
189
313
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
68.1
465
1820
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
63.0
68.0
79
13
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
15.2
67.5
114
79
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
678.8
67.3
66
*
L04AA06
ATC
mycophenolic acid; systemic
12.9
66.7
121
99
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
175.4
65.4
68
*
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
+∞
64.9
62
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
+∞
63.9
61
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
47.8
60.9
74
16
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
26.4
60.3
84
33
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
12.9
59.7
108
88
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.5
59.6
188
371
K50.9
ICD-10 Finland
Crohn disease, unspecified
12.0
58.9
110
96
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
16.8
58.7
95
59
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
18.1
58.5
92
53
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.6
58.0
178
340
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
48.1
57.7
70
15
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
68.0
57.5
66
10
K50.1
ICD-10 Finland
Crohn disease of large intestine
13.7
57.0
100
76
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
572.7
56.9
56
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
198.5
56.3
58
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
18.3
56.2
88
50
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
54.7
794
4578
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
39.0
53.8
68
18
JN4AD
NOMESCO Finland
Body CT examination
3.6
53.0
258
777
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
52.6
437
1898
JJ5AT
NOMESCO Finland
NA
272.3
52.4
53
*
ZX120
NOMESCO Finland
Intravenous
3.3
52.1
295
997
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
20.7
52.1
78
39
H02AB06
ATC
prednisolone; systemic
2.0
51.9
1052
6927
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.1
51.8
218
578
Z51.5
ICD-10 Finland
Palliative care
3.9
51.1
224
616
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
11.9
50.8
95
83
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
49.3
504
2437
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
48.8
304
1098
WX004
NOMESCO Finland
Patient-controlled sedation
37.5
48.7
62
17
57505
ICD-8 Finland
Cholecystitis and cholangitis, without mention of calculus, Cholangitis alia sive NUD
+∞
48.1
46
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.6
46.6
92
90
D98
ICPC
Cholecystitis/cholelithiasis
87.1
46.0
51
6
JAH00
NOMESCO Finland
Laparotomy
6.9
45.9
119
182
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
457.0
45.4
45
*
A41.8
ICD-10 Finland
Other specified sepsis
8.6
45.0
100
121
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.2
44.4
178
450
C10AC01
ATC
colestyramine; oral
7.6
44.2
106
145
A04AA02
ATC
granisetron; systemic, transdermal
3.9
43.8
194
537
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
8.6
43.2
96
116
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
42.8
41
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.4
42.8
226
721
J01DB01
ATC
cefalexin; oral
2.0
42.5
1685
13779
K86.3
ICD-10 Finland
Pseudocyst of pancreas
+∞
40.7
39
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
12.8
40.6
73
59
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
49.0
39.9
48
10
TJK01
NOMESCO Finland
Laparoscopic cholangiography
+∞
39.7
38
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
65.6
39.2
45
7
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
394.4
39.2
39
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
39.1
415
2019
B01AB05
ATC
enoxaparin; parenteral
2.0
38.8
661
3937
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
7.2
38.7
96
138
JN4BD
NOMESCO Finland
Extensive body CT
2.7
38.2
296
1217
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
37.9
147
360
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
37.8
714
4413
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
16.5
37.8
61
38
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
51.0
37.7
45
9
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
37.1
255
971
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
37.0
295
1230
A07EA02
ATC
hydrocortisone; rectal
6.2
36.5
101
169
K50.0
ICD-10 Finland
Crohn disease of small intestine
8.3
35.9
81
101
JAH01
NOMESCO Finland
Laparoscopy
4.9
35.8
122
262
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.1
35.6
208
712
K92.1
ICD-10 Finland
Melaena
3.6
35.4
170
502
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
352.8
35.0
35
*
H02AB07
ATC
prednisone; oral
2.3
34.9
359
1709
L01BC06
ATC
capecitabine; oral
4.8
34.9
120
260
K83.3
ICD-10 Finland
Fistula of bile duct
+∞
34.5
33
*
TJK00
NOMESCO Finland
Intraoperative cholangiography
+∞
34.5
33
*
5742A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
+∞
34.5
33
*
K86.8
ICD-10 Finland
Other specified diseases of pancreas
332.0
33.0
33
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.2
32.6
105
212
TK800
NOMESCO Finland
Hemodialysis
5.9
32.2
92
161
L01BB02
ATC
mercaptopurine; oral
11.6
32.1
60
53
UJF92
NOMESCO Finland
Capsular endoscopy
6.9
31.9
81
121
6663
FHL
Cholecystectomy and cholangiography
167.4
31.8
33
*
C03CA01
ATC
furosemide; systemic
1.8
31.5
683
4367
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
+∞
31.3
30
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
15.8
31.3
51
33
L04AA01
ATC
[U] ciclosporin; systemic
7.6
31.2
74
100
R4190
NOMESCO Finland
Nutritional therapy
4.4
31.2
118
282
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
31.1
1008
7304
K86.2
ICD-10 Finland
Cyst of pancreas
162.3
30.7
32
*
SPAT1262
SPAT
Handing over of treatment supplies
2.1
30.6
412
2203
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
18.8
30.1
46
25
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.1
29.9
121
308
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.4
29.7
112
267
WVA20
NOMESCO Finland
Medicine administration
5.9
29.6
85
150
H02AB04
ATC
methylprednisolone; systemic
2.2
29.3
341
1708
JKB00
NOMESCO Finland
Incision of bile duct
+∞
29.2
28
*
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
15.3
29.1
48
32
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.1
29.1
119
306
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
23.9
28.3
40
17
A02BC05
ATC
esomeprazole; systemic
1.7
28.2
785
5387
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
39.5
28.1
35
9
WX419
NOMESCO Finland
Other general anesthesy
8.7
28.0
61
72
R94.5
ICD-10 Finland
Abnormal results of liver function studies
10.4
28.0
55
54
K51
ICD-10 Finland
Ulcerative colitis
12.1
28.0
51
43
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.7
28.0
206
814
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
20.9
27.8
41
20
WX892
NOMESCO Finland
Monitored bed care
2.7
27.5
197
766
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
27.3
363
1922
JK3MB
NOMESCO Finland
Postoperative cholangiography
+∞
27.1
26
*
JKB20
NOMESCO Finland
Intraoperative cholangioscopy
+∞
27.1
26
*
JJA20
NOMESCO Finland
Open biopsy of liver
32.3
26.9
35
11
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.0
26.7
61
78
R11
ICD-10 Finland
Nausea and vomiting
2.6
26.6
202
813
SPAT1255
SPAT
Intravenous administration of medicine
2.9
26.6
172
628
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
22.7
26.5
38
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.8
26.2
115
315
K75.0
ICD-10 Finland
Abscess of liver
37.2
26.2
33
9
K81.1
ICD-10 Finland
Chronic cholecystitis
+∞
26.1
25
*
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
60.8
26.0
30
5
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
73.6
25.8
29
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
20.3
25.6
38
19
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
11.4
25.6
48
43
A10AE04
ATC
insulin glargine; parenteral
2.5
25.6
222
961
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
15.3
25.6
42
28
R4110
NOMESCO Finland
Physiotherapy
1.8
25.3
547
3450
C24.00
ICD-10 Finland
Hepatic duct
+∞
25.0
24
*
5761X
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS ALIA]
+∞
25.0
24
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
11.1
24.9
47
43
WZC30
NOMESCO Finland
Teaching
2.2
24.8
287
1430
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
24.8
157
566
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.4
24.6
92
218
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.4
24.4
123
378
A06AD11
ATC
lactulose; oral
2.0
24.3
355
1943
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
24.2
133
436
JKE15
NOMESCO Finland
Endoscopic lithotripsy in bile duct
+∞
24.0
23
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
38.0
23.9
30
8
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
242.5
23.7
24
*
3AC01
NOMESCO Finland
NA
8.4
23.6
52
63
6662
FHL
Cholecystectomy
126.4
23.6
25
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
10.9
23.6
45
42
UJD02
NOMESCO Finland
Gastroscopy
3.1
23.5
137
467
H02AB02
ATC
dexamethasone; systemic
2.3
23.5
240
1127
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
19.7
23.5
35
18
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
23.3
351
1944
UJF02
NOMESCO Finland
Peroral enteroscopy
15.4
23.3
38
25
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
23.2
289
1484
B01AB10
ATC
tinzaparin; parenteral
2.7
23.2
165
640
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.2
23.1
72
141
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
18.7
23.0
35
19
H02AB09
ATC
hydrocortisone; systemic
4.7
23.0
79
172
57409
ICD-8 Finland
Cholelithiasis, Unspecified
+∞
23.0
22
*
D02
ICPC
Abdominal pain epigastric
3.2
22.6
122
395
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
32.6
22.4
29
9
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.9
22.4
63
109
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.6
22.2
103
296
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
21.7
230
1095
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
20.9
21.2
31
15
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
21.2
527
3439
57401
ICD-8 Finland
Cholelithiasis, Cum cholecystitide chronica
+∞
20.9
20
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.8
20.8
135
494
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
19.6
20.8
31
16
WW500
NOMESCO Finland
Blood transfusion
3.2
20.8
114
373
Z94.0
ICD-10 Finland
Kidney transplant status
7.5
20.7
49
67
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
77.6
20.7
23
*
C03DA01
ATC
spironolactone; oral
2.1
20.6
250
1266
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
30.3
20.6
27
9
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.7
20.5
70
152
R18
ICD-10 Finland
Ascites
5.1
20.4
65
131
A04AA01
ATC
ondansetron; systemic, rectal
2.6
20.2
150
595
I81
ICD-10 Finland
Portal vein thrombosis
16.2
20.1
32
20
D76
ICPC
Malignant neoplasm pancreas
23.6
20.0
28
12
A02BC01
ATC
omeprazole; systemic
1.7
19.9
550
3686
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
19.8
468
2997
WX882
NOMESCO Finland
High dependency care
3.5
19.7
94
277
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
19.6
361
2138
8140/3-C25.0
ICD-O-3
Adenocarcinoma, NOS, of head of pancreas
201.7
19.6
20
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
24.8
19.5
27
11
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
19.6
19.5
29
15
A06AH03
ATC
naloxegol; oral
7.0
19.5
48
70
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.7
19.2
66
145
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
12.9
18.9
33
26
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
+∞
18.8
18
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
18.8
236
1211
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.4
18.6
91
274
K83
ICD-10 Finland
Other diseases of biliary tract
100.9
18.6
20
*
K92.0
ICD-10 Finland
Haematemesis
4.0
18.5
74
188
WX110
NOMESCO Finland
Local anesthesy
1.5
18.4
1260
10433
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.3
18.3
56
108
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
21.9
18.2
26
12
R53
ICD-10 Finland
Malaise and fatigue
1.7
18.0
400
2508
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
17.9
168
754
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
26.9
17.8
24
9
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
17.7
17
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
17.6
420
2688
JKD50
NOMESCO Finland
Hepatoportoenterostomy
181.4
17.5
18
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
10.8
17.4
33
31
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
5.4
17.3
52
99
A07EC01
ATC
sulfasalazine; oral, rectal
2.2
17.3
181
857
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
17.2
171
788
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.7
17.0
75
208
K29.7
ICD-10 Finland
Gastritis, unspecified
3.4
16.9
83
252
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
16.8
158
712
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
16.7
16
*
JL5CM
NOMESCO Finland
Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet
+∞
16.7
16
*
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
+∞
16.7
16
*
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
+∞
16.7
16
*
A07AA11
ATC
rifaximin; oral
35.3
16.7
21
6
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
35.3
16.7
21
6
R10.0
ICD-10 Finland
Acute abdomen
3.7
16.6
72
197
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
12.8
16.6
29
23
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
16.6
258
1434
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
90.8
16.6
18
*
WX872
NOMESCO Finland
Intensive care
2.6
16.5
119
466
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
171.2
16.5
17
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
27.8
16.5
22
8
A28
ICPC
Limited function/disability NOS
1.8
16.5
323
1943
D97
ICPC
Liver disease NOS
13.5
16.5
28
21
1370
FHL
Colonoscopy, whole colon
12.2
16.3
29
24
L04AC05
ATC
ustekinumab; parenteral
14.4
16.3
27
19
A07EA01
ATC
prednisolone; rectal
11.2
16.2
30
27
B03BA03
ATC
hydroxocobalamin; parenteral
2.4
16.1
141
613
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.4
16.0
48
91
C24.1
ICD-10 Finland
Malignant neoplasm: Ampulla of Vater
47.9
16.0
19
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.1
16.0
62
154
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
5.6
15.9
46
84
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.9
15.8
99
356
Z93.2
ICD-10 Finland
Ileostomy status
15.8
15.7
25
16
L04AB04
ATC
adalimumab; parenteral
4.7
15.7
53
115
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
9.3
15.7
32
35
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
15.6
15
*
UJK52
NOMESCO Finland
Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography
+∞
15.6
15
*
L04AA05
ATC
[U] tacrolimus; systemic
85.7
15.6
17
*
C24.0
ICD-10 Finland
Malignant neoplasm: Extrahepatic bile duct
161.1
15.5
16
*
C24.02
ICD-10 Finland
Common bile duct
161.1
15.5
16
*
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
161.1
15.5
16
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
12.4
15.3
27
22
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
15.3
218
1172
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
6.5
15.2
39
61
D94
ICPC
Chronic enteritis/ulcerative colitis
9.2
15.2
31
34
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
15.1
83
274
JDE00
NOMESCO Finland
Gastrojejunostomy
20.2
15.1
22
11
A07AA09
ATC
vancomycin; oral
5.6
15.0
43
78
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
31.9
14.8
19
6
N03AX16
ATC
pregabalin; oral
1.6
14.7
409
2718
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.4
14.7
72
219
A02BA02
ATC
ranitidine; systemic
1.6
14.7
382
2493
K83.5
ICD-10 Finland
Biliary cyst
+∞
14.6
14
*
57408
ICD-8 Finland
Cholelithiasis, Alia definita
+∞
14.6
14
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
14.6
14
*
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
+∞
14.6
14
*
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
14.6
511
3597
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
14.5
441
2997
Q44.29
ICD-10 Finland
Atresia of bile ducts
150.9
14.5
15
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
14.4
155
745
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
14.4
337
2134
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
14.3
195
1032
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
14.3
278
1666
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
14.3
158
765
WX704
NOMESCO Finland
Intubation
2.3
14.2
141
650
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
14.2
101
393
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
14.2
117
494
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
42.8
14.1
17
*
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
42.8
14.1
17
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
42.8
14.1
17
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
13.8
193
1029
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
17.7
13.8
21
12
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
13.7
442
3040
A10AE05
ATC
insulin detemir; parenteral
2.4
13.7
120
523
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
6.4
13.7
35
55
L04AA10
ATC
sirolimus; oral
75.6
13.6
15
*
K82.2
ICD-10 Finland
Perforation of gallbladder
+∞
13.6
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.3
13.5
49
115
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
34.2
13.5
17
5
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
140.8
13.5
14
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
140.8
13.5
14
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
25.9
13.4
18
7
E0000UV
ATC
NA
1.5
13.3
714
5491
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
5.6
13.3
38
69
N02BE01
ATC
paracetamol; systemic, rectal
1.5
13.2
1640
14753
K80
ICD-10 Finland
Cholelithiasis
9.1
13.2
27
30
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
9.1
13.2
27
30
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
9.7
13.2
26
27
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
3.5
13.2
60
173
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
13.2
93
359
D01
ICPC
Abdominal pain/cramps general
2.0
13.1
182
971
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.1
13.1
50
124
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.5
13.0
103
427
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
12.9
275
1693
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
12.9
100
410
T90
ICPC
Diabetes non-insulin dependent
1.6
12.8
405
2770
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
50.3
12.8
15
*
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
12.8
197
1090
A11CC03
ATC
alfacalcidol; systemic
3.5
12.8
60
177
B01AB04
ATC
dalteparin; parenteral
2.4
12.8
107
454
5770A
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]
+∞
12.5
12
*
K81.8
ICD-10 Finland
Other cholecystitis
+∞
12.5
12
*
5741A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]
+∞
12.5
12
*
K83.4
ICD-10 Finland
Spasm of sphincter of Oddi
+∞
12.5
12
*
RS220
NOMESCO Finland
NA
4.9
12.5
40
83
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
9.4
12.5
25
27
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
20.1
12.4
18
9
XF612
NOMESCO Finland
Measurement of central venous pressure
13.2
12.4
21
16
L03AA02
ATC
filgrastim; parenteral
3.2
12.4
65
209
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.8
12.3
81
301
SPAT1254
SPAT
Administration of medicine
1.7
12.3
296
1886
J02AC01
ATC
fluconazole; systemic
1.4
12.1
621
4712
SPAT1263
SPAT
Sampling
1.4
12.1
776
6144
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.3
12.0
108
477
A02BC03
ATC
lansoprazole; oral
1.5
12.0
515
3770
J01FF01
ATC
clindamycin; systemic
1.5
11.8
482
3485
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
11.7
41
94
6611
FHL
Needle biopsy in the operating room
30.2
11.6
15
5
K31.5
ICD-10 Finland
Obstruction of duodenum
65.3
11.6
13
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.3
11.5
57
176
JK3RT
NOMESCO Finland
Percutaneous transhepatic removal of stones from bile ducts
+∞
11.5
11
*
JK1AT
NOMESCO Finland
Cathetrisation of bile cyst with radiological guidance
+∞
11.5
11
*
8160/3-C24.0
ICD-O-3
Cholangiocarcinoma of extrahepatic bile duct
+∞
11.5
11
*
6664
FHL
Cholecystectomy and choledocotomy
+∞
11.5
11
*
57403
ICD-8 Finland
Cholelithiasis, Choledocholithiasis
+∞
11.5
11
*
N30.0
ICD-10 Finland
Acute cystitis
1.7
11.5
247
1524
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
120.6
11.4
12
*
JKB21
NOMESCO Finland
Laparoscopic cholangioscopy
120.6
11.4
12
*
H26.3
ICD-10 Finland
Drug-induced cataract
7.5
11.4
26
35
S18
ICPC
Laceration/cut
1.4
11.2
760
6062
K74.0
ICD-10 Finland
Hepatic fibrosis
20.1
11.1
16
8
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
8.1
11.1
24
30
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
10.1
11.0
21
21
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
43.5
10.9
13
*
JFB00
NOMESCO Finland
Partial resection of small intestine
4.1
10.9
41
101
J01MA14
ATC
moxifloxacin; systemic
1.9
10.9
160
869
RD210
NOMESCO Finland
NA
3.8
10.9
44
116
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
10.8
127
634
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
10.8
187
1075
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
10.8
693
5458
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
10.8
147
777
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
28.2
10.7
14
5
K30
ICD-10 Finland
Functional dyspepsia
1.9
10.7
166
920
K76.89
ICD-10 Finland
Other specified diseases of liver
21.6
10.7
15
7
JFC00
NOMESCO Finland
Entero-enterostomy
21.6
10.7
15
7
B01AA03
ATC
warfarin; systemic
1.5
10.6
425
3057
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.0
10.6
25
36
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
10.6
54
172
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
6.6
10.5
26
40
57709
ICD-8 Finland
Diseases of pancreas, Pancreatitis NUD
+∞
10.4
10
*
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
10.4
10
*
5714X
ICD-9 Finland
Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]
+∞
10.4
10
*
Q44.3
ICD-10 Finland
Congenital stenosis and stricture of bile ducts
+∞
10.4
10
*
5740A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]
+∞
10.4
10
*
A03
ICPC
Fever
1.6
10.4
265
1711
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
10.4
69
259
K65.0
ICD-10 Finland
Acute peritonitis
4.8
10.4
33
69
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
10.3
119
590
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
32.7
10.3
13
*
Z53.8
ICD-10 Finland
Procedure not carried out for other reasons
18.9
10.3
15
8
K72.1
ICD-10 Finland
Chronic hepatic failure
23.5
10.2
14
6
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.9
10.2
40
103
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.7
10.1
28
50
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.8
10.0
64
236
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
10.1
10.0
19
19
K76.6
ICD-10 Finland
Portal hypertension
40.2
10.0
12
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
40.2
10.0
12
*
A41.4
ICD-10 Finland
Sepsis due to anaerobes
16.8
9.9
15
9
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
9.9
120
610
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
9.9
1066
9106
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
26.1
9.8
13
5
A12AA04
ATC
calcium carbonate; oral
3.9
9.8
39
102
AA1AD
NOMESCO Finland
CT of head and brain
1.5
9.8
439
3227
XX4BW
NOMESCO Finland
NA
13.4
9.7
16
12
57309
ICD-8 Finland
Other diseases of liver, Unspecified
11.4
9.6
17
15
JAD10
NOMESCO Finland
Repair of incisional hernia
6.4
9.5
24
38
JMA10
NOMESCO Finland
Transabdominal total splenectomy
7.2
9.5
22
31
E87.6
ICD-10 Finland
Hypokalaemia
2.7
9.5
62
233
JLD12
NOMESCO Finland
Endoscopic drainage of pancreatic pseudocyst
100.4
9.4
10
*
JK3PB
NOMESCO Finland
Peroperative cholangiography
100.4
9.4
10
*
JKD30
NOMESCO Finland
Extrahepatic anastomosis of right or left hepatic duct to jejunum
100.4
9.4
10
*
K73.89
ICD-10 Finland
Other long-term hepatitis, not classified differently
+∞
9.4
9
*
Q44.4
ICD-10 Finland
Choledochal cyst
+∞
9.4
9
*
5745A
ICD-9 Finland
Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
+∞
9.4
9
*
JK2AT
NOMESCO Finland
Puncture of bile cyst with ultrasound guidance
+∞
9.4
9
*
57400
ICD-8 Finland
Cholelithiasis, Cum cholecystitide acuta
+∞
9.4
9
*
57500
ICD-8 Finland
Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta
+∞
9.4
9
*
5770D
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]
+∞
9.4
9
*
JKC30
NOMESCO Finland
Partial excision of bile duct and anastomosis to jejunum
+∞
9.4
9
*
JLB12
NOMESCO Finland
Transduodenal endoscopic incision of pancreatic duct orifice
+∞
9.4
9
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
9.3
223
1414
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
9.3
493
3734
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.7
9.2
30
65
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
4.5
9.1
31
70
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
9.1
463
3483
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.0
9.0
34
85
C08CA01
ATC
amlodipine; oral
1.4
9.0
639
5090
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
9.0
546
4235
B81
ICPC
Anaemia vit B12/folate deficiency
2.3
9.0
78
343
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.6
8.9
64
253
K56.7
ICD-10 Finland
Ileus, unspecified
3.4
8.9
41
122
C07AA05
ATC
propranolol; systemic
1.5
8.8
307
2134
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
8.7
303
2109
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.4
8.7
40
119
4AA12
NOMESCO Finland
NA
8.2
8.6
18
22
J01DA01
ATC
[U] cefalexin; systemic
1.3
8.5
1130
9855
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.0
8.5
46
154
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
10.1
8.5
16
16
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
8.5
446
3370
JLC10
NOMESCO Finland
Distal pancreatectomy
20.1
8.5
12
6
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
8.5
463
3521
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.4
8.4
24
45
L28
ICPC
Limited function/disability (L)
1.5
8.4
283
1952
8000/3-C24.0
ICD-O-3
Neoplasm, malignant of extrahepatic bile duct
90.4
8.4
9
*
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
90.4
8.4
9
*
7824A
ICD-9 Finland
Symptoms involving skin and other integumentary tissue, Jaundice, unspecified, not of newborn
90.4
8.4
9
*
JFF13
NOMESCO Finland
Terminal enterostomy
12.8
8.4
14
11
5750A
ICD-9 Finland
Other disorders of gallbladder, Acute cholecystitis
+∞
8.3
8
*
K82.0
ICD-10 Finland
Obstruction of gallbladder
+∞
8.3
8
*
JKB01
NOMESCO Finland
Laparoscopic incision of bile duct
+∞
8.3
8
*
K73.8
ICD-10 Finland
Other chronic hepatitis, not elsewhere classified
+∞
8.3
8
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
8.3
300
2102
T89
ICPC
Diabetes insulin dependent
2.4
8.3
70
302
SPAT1125
SPAT
Stoma care and guidance
3.1
8.3
43
140
D99
ICPC
Disease digestive system other
4.3
8.3
29
68
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
8.3
317
2250
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
8.3
746
6151
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
8.3
135
766
5AB14
NOMESCO Finland
NA
14.5
8.2
13
9
8000/3-C25.0
ICD-O-3
Neoplasm, malignant of head of pancreas
14.5
8.2
13
9
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
8.2
377
2777
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.5
8.2
27
60
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.4
8.2
64
268
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.2
47
163
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.7
8.1
26
56
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.8
8.1
48
171
C25
ICD-10 Finland
Malignant neoplasm of pancreas
33.5
8.1
10
*
4AA33
NOMESCO Finland
NA
33.5
8.1
10
*
R52.0
ICD-10 Finland
Acute pain
2.7
8.0
52
195
N18.8
ICD-10 Finland
Other chronic renal failure
2.4
8.0
63
264
E13
ICD-10 Finland
Other specified diabetes mellitus
22.1
8.0
11
5
N05CF01
ATC
zopiclone; oral
1.4
7.9
566
4496
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
7.9
161
979
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.2
7.8
23
45
M05BA04
ATC
alendronic acid; oral
1.7
7.8
157
948
ZX108
NOMESCO Finland
Inhalation
4.7
7.8
25
54
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.0
7.8
100
523
UKC02
NOMESCO Finland
Cystoscopy
1.5
7.7
297
2107
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
7.7
301
2144
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
5.0
7.7
23
46
JFA65
NOMESCO Finland
Endoscopic insertion of ileum stent
45.1
7.7
9
*
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
15.1
7.7
12
8
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.6
7.7
21
38
R31
ICD-10 Finland
Unspecified haematuria
1.6
7.6
184
1170
D77
ICPC
Malignant digestive neopl other/NOS
6.7
7.6
18
27
JFH10
NOMESCO Finland
Total colectomy and ileostomy
8.9
7.5
15
17
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
5.8
7.5
20
35
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.8
7.5
45
163
SPAT1234
SPAT
Support of social functional capacity
1.9
7.4
99
525
A06AC51
ATC
ispaghula, combinations; systemic
2.0
7.4
88
444
JFF10
NOMESCO Finland
Loop enterostomy
6.0
7.4
19
32
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
7.3
74
350
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.3
525
4168
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
7.3
137
813
57608
ICD-8 Finland
Other diseases of gallbladder and biliary, Dyskinesia viarum biliferarum
+∞
7.3
7
*
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
7.3
7
*
JLA00
NOMESCO Finland
Exploration of pancreas
+∞
7.3
7
*
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
7.3
7
*
JLB35
NOMESCO Finland
Transduodenal endoscopic extraction of foreign body from pancreatic duct
+∞
7.3
7
*
57708
ICD-8 Finland
Diseases of pancreas, Pancreatitis acuta alia
+∞
7.3
7
*
T86.4
ICD-10 Finland
Liver transplant failure and rejection
+∞
7.3
7
*
6672
FHL
Cholecocenterostomy
+∞
7.3
7
*
57402
ICD-8 Finland
Cholelithiasis, Cum cholecystitide et choledocholithiasi
+∞
7.3
7
*
K86.0
ICD-10 Finland
Alcohol-induced chronic pancreatitis
+∞
7.3
7
*
5745B
ICD-9 Finland
Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,CUM OBSTR]
+∞
7.3
7
*
6615
FHL
Liver transplant
+∞
7.3
7
*
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.1
7.3
83
412
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
6.2
7.2
18
29
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
7.2
191
1245
5739X
ICD-9 Finland
Other disorders of liver, Unspecified disorder of liver
15.8
7.2
11
7
K56.0
ICD-10 Finland
Paralytic ileus
4.3
7.2
25
59
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.4
7.1
32
95
A07DA03
ATC
loperamide; oral
2.2
7.1
70
328
107
Kela drug reimbursment
Pernicious anaemia
2.9
7.1
41
144
SPAT1325
SPAT
Vaccination
1.3
7.0
629
5157
A07AA02
ATC
nystatin; oral
1.8
7.0
109
610
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.5
6.9
19
35
WX725
NOMESCO Finland
Noninvasive ventilation
2.0
6.9
81
410
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
6.9
270
1922
TJF80
NOMESCO Finland
Ostomy education
3.7
6.9
28
77
N05BA04
ATC
oxazepam; oral
1.4
6.9
414
3191
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
6.8
156
980
K59.09
ICD-10 Finland
Constipation, unspecified
1.8
6.8
106
593
R06.0
ICD-10 Finland
Dyspnoea
1.4
6.8
411
3166
SPAT1216
SPAT
Assessment of functional ability
1.5
6.8
272
1946
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.9
6.8
90
474
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.0
6.8
20
40
ZXA00
NOMESCO Finland
Right side
1.3
6.8
469
3694
JF1BD
NOMESCO Finland
Very extensive small bowel CT
6.1
6.8
17
28
5550A
ICD-9 Finland
Regional enteritis, Small intestine
40.2
6.8
8
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
6.7
98
537
253
Kela drug reimbursment
NA
16.7
6.7
10
6
3042
Kela drug reimbursment
NA
16.7
6.7
10
6
4AB02
NOMESCO Finland
NA
7.2
6.7
15
21
SPAT1211
SPAT
Application of soft bandage
1.6
6.7
159
1009
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
6.7
564
4574
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
4.4
6.6
22
50
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
6.6
299
2188
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.5
6.6
48
195
SPAT1301
SPAT
No procedures
1.3
6.6
551
4460
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
6.6
269
1932
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
3.5
6.6
28
80
XW000
NOMESCO Finland
Bone marrow biopsy
2.0
6.6
74
369
N17.8
ICD-10 Finland
Other acute renal failure
3.7
6.6
26
70
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
8.7
6.5
13
15
S97
ICPC
Chronic ulcer skin
1.9
6.5
96
527
B34.9
ICD-10 Finland
Viral infection, unspecified
2.4
6.5
50
208
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
6.5
59
268
A04
ICPC
Weakness/tiredness general
1.5
6.5
224
1555
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
6.5
123
735
A46
ICD-10 Finland
Erysipelas
1.5
6.5
243
1715
J01CA08
ATC
pivmecillinam; oral
1.3
6.4
592
4855
JK3AN
NOMESCO Finland
Biliary tract isotope imaging
70.0
6.4
7
*
K82.9
ICD-10 Finland
Disease of gallbladder, unspecified
70.0
6.4
7
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
6.4
53
231
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.1
6.4
23
57
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
6.4
108
624
K59.1
ICD-10 Finland
Functional diarrhoea
1.9
6.3
84
445
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
5.5
6.3
17
31
RS120
NOMESCO Finland
NA
11.0
6.3
11
10
N03AX12
ATC
gabapentin; oral
1.5
6.3
238
1684
L29.8
ICD-10 Finland
Other pruritus
3.7
6.3
25
68
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
18.1
6.3
9
5
K71.2
ICD-10 Finland
Toxic liver disease with acute hepatitis
18.1
6.3
9
5
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
+∞
6.3
6
*
BE00A
NOMESCO Finland
NA
+∞
6.3
6
*
1282
FHL
ERCP and sphincterotomy
+∞
6.3
6
*
6673
FHL
Hepatic enterostomy
+∞
6.3
6
*
5770C
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]
+∞
6.3
6
*
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
6.3
6
*
6653
FHL
Cholecocotomy or hepaticotomy and choledocoscopy (includes stone removal)
+∞
6.3
6
*
5762A
ICD-9 Finland
Other disorders of biliary tract, Obstruction of bile duct
+∞
6.3
6
*
JKF96
NOMESCO Finland
Other secondary operation on biliary tract
+∞
6.3
6
*
Q44.1
ICD-10 Finland
Other congenital malformations of gallbladder
+∞
6.3
6
*
5761B
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS CHRONICA]
+∞
6.3
6
*
XX9XB
NOMESCO Finland
Other X-ray examination with contrast
26.7
6.2
8
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
26.7
6.2
8
*
J01XX08
ATC
linezolid; systemic
5.0
6.2
18
36
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
5.0
6.2
18
36
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.8
6.2
24
64
SPAT1153
SPAT
Removal of sutures
1.3
6.2
532
4325
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
5.3
6.1
17
32
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
6.1
139
872
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.4
6.1
47
196
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
12.5
6.1
10
8
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
6.1
56
257
J01FA06
ATC
roxithromycin; oral
1.3
6.1
671
5635
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.1
6.1
30
97
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.0
6.0
70
354
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.0
6.0
72
368
ZX121
NOMESCO Finland
Central venous catheter
6.7
6.0
14
21
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
6.7
6.0
14
21
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.2
6.0
29
92
K29.6
ICD-10 Finland
Other gastritis
3.4
6.0
26
76
V03AE01
ATC
polystyrene sulfonate; oral
3.0
6.0
32
109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
1676
7434
5.24
319.19
17.8
9.7
inr
1.2
1.3
5.97
474
2105
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1046
1606
10.83
307.65
6.2
2.0
g/l
0.2
0.2
7.06
1020
1477
(3005719) IgG [Mass/volume] in Serum or Plasma
767
1273
8.41
307.65
3.9
2.8
g/l
11.7
10.5
10.17
723
1156
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1979
9044
8.04
307.65
25.4
5.6
umol/l
17.9
12.0
24.13
1940
8549
(3024980) IgG subclass 4 [Mass/volume] in Serum
525
196
34.08
307.65
2.8
1.4
g/l
0.8
1.0
0.73
446
158
(3034770) Mitochondria Ab [Titer] in Serum
640
409
21.03
307.65
2.4
1.2
titre
639.2
593.6
0.06
12
11
(40768441) Liver Pathology biopsy report
312
110
32.49
307.65
2.2
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1376
5106
5.02
307.65
8.5
4.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
470
295
19.60
307.65
6.3
3.2
u/ml
243.7
1291.2
0.63
437
272
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
276
126
24.65
307.65
1.8
1.4
umol/l
11.3
13.1
1.85
276
118
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
420
460
10.87
307.65
2.5
1.3
iu/ml
9.7
23.0
—
16
7
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
776
1475
7.32
307.65
8.0
1.8
u/l
43.6
33.4
1.83
741
1247
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
539
114
60.82
307.65
2.3
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
829
543
22.89
307.65
6.6
2.8
u/ml
576.1
2474.1
0.51
765
460
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1097
1754
10.74
307.65
6.6
4.1
ug/l
10.3
26.9
1.37
931
1434
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1080
1723
10.64
307.65
10.8
2.3
umol/l
17.6
7.6
16.36
1021
1491
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
447
580
9.26
307.65
2.5
1.5
titre
276.7
213.9
0.33
12
23
(3007566) Smooth muscle Ab [Titer] in Serum
639
409
20.99
307.65
2.4
1.1
titre
74.5
79.7
0.13
64
36
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1538
5134
6.64
307.65
7.9
2.1
u/l
61.8
56.2
1.30
1492
4711
(3028026) IgM [Mass/volume] in Serum or Plasma
696
1006
9.36
307.65
2.8
1.8
g/l
1.3
1.5
0.97
663
914
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
322
129
28.71
307.65
1.7
1.1
titre
317.0
85.0
5.69
109
18
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1507
5477
5.77
307.65
12.7
2.9
u/l
48.8
36.2
3.71
1462
5205
(3024561) Albumin [Mass/volume] in Serum or Plasma
1747
7916
5.53
307.65
16.1
4.5
g/l
33.6
35.4
28.28
1692
7307
(3033658) Prothrombin time (PT) actual/Normal
1242
4544
4.62
300.07
14.2
3.8
%
88.7
87.7
0.72
1219
4427
(3009445) Proteinase 3 Ab [Units/volume] in Serum
469
734
7.71
296.93
2.5
1.4
u/ml
5.5
11.2
0.72
75
20
(3048689) Calprotectin [Mass/mass] in Stool
742
1978
5.00
264.94
5.4
2.4
ug/g
192.8
142.1
2.47
664
1563
(3042936) Bacteria identified in Isolate by Culture
819
2497
4.48
244.16
2.8
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
754
2192
4.57
238.66
2.5
1.3
titre
555.0
508.7
0.25
230
459
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
285
340
9.39
224.86
7.5
5.6
iu/ml
849.6
616.1
0.23
63
53
(3044640) Blood type and Crossmatch panel - Blood
1279
5581
3.79
224.15
4.5
2.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
162
73
23.74
223.16
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
233
220
11.63
217.64
1.2
1.1
g/l
1.6
1.5
4.20
218
197
(3023183) Ammonium ion [Moles/volume] in Plasma
279
344
9.05
214.25
5.4
2.6
umol/l
36.1
36.8
0.08
245
291
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
532
1300
4.98
206.98
2.3
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
644
1834
4.44
206.43
2.6
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
288
394
8.18
202.73
1.5
1.3
ug/g
174.1
312.1
16.55
172
229
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
151
73
22.02
201.94
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
151
73
22.02
201.94
1.1
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
758
2470
4.04
201.50
2.9
2.6
%
22.0
22.5
0.40
671
2115
(3020779) Urea [Moles/volume] in Serum or Plasma
605
1695
4.44
197.38
12.7
7.1
mmol/l
9.0
10.1
3.04
585
1611
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
136
60
23.98
188.62
4.4
2.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
770
2641
3.83
188.49
2.9
2.5
g/l
2.3
2.3
0.31
722
2443
(3022948) Iron [Moles/volume] in Serum or Plasma
797
2883
3.65
178.83
3.0
2.5
umol/l
12.0
12.9
2.47
757
2664
(3013826) Glucose [Moles/volume] in Serum or Plasma
1805
10787
3.78
176.49
11.1
4.6
mmol/l
6.8
6.7
1.82
1766
10091
(3007164) IgA [Mass/volume] in Serum or Plasma
861
3306
3.51
175.53
2.6
1.5
g/l
2.6
2.4
1.22
725
1962
(42870588) Differential panel, method unspecified - Blood
1280
6276
3.25
173.17
11.2
5.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1499
8228
3.22
163.65
7.0
4.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2065
13868
4.68
161.32
30.1
6.9
u/l
155.2
77.9
111.16
2032
12960
(3010375) cycloSPORINE [Mass/volume] in Blood
127
74
18.07
155.82
34.6
29.8
ug/l
127.3
128.6
0.05
114
63
(3013650) Neutrophils [#/volume] in Blood by Automated count
1732
10531
3.37
154.75
18.7
8.8
e9/l
4.3
4.1
2.85
1609
9124
(3026250) Tacrolimus [Mass/volume] in Blood
124
70
18.63
154.44
40.5
31.5
ug/l
7.0
7.1
0.16
110
63
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1816
11370
3.52
154.18
13.2
2.9
u/l
168.5
44.5
87.17
1756
10513
(3016650) Hepatitis A virus Ab [Presence] in Serum
192
231
8.95
149.40
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
226
335
7.35
147.25
1.4
1.4
u/ml
376.7
250.8
3.49
136
187
(3019069) Monocytes/100 leukocytes in Blood
1502
8573
3.04
146.85
12.7
6.2
%
8.7
8.8
0.22
1449
8008
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
232
356
7.11
146.42
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
960
4300
3.07
146.31
4.3
2.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1469
8303
3.01
145.86
12.4
6.0
%
0.7
0.7
0.50
1416
7739
(3006504) Eosinophils/100 leukocytes in Blood
1492
8540
3.00
144.07
12.4
6.0
%
2.8
2.9
0.45
1436
7949
(3024139) IgG subclass 3 [Mass/volume] in Serum
144
125
12.20
141.36
1.8
1.2
g/l
0.4
0.4
0.21
82
96
(3028192) IgG subclass 2 [Mass/volume] in Serum
144
125
12.20
141.36
1.8
1.2
g/l
3.4
2.8
1.98
81
95
(3027135) IgG subclass 1 [Mass/volume] in Serum
144
125
12.20
141.36
1.8
1.2
g/l
7.9
6.9
1.33
82
95
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
225
347
7.06
141.24
1.6
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
554
1817
3.67
140.67
1.7
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
634
2277
3.43
139.67
11.1
6.9
mmol/l
104.6
104.3
1.04
625
2221
(3002030) Lymphocytes/100 leukocytes in Blood
1512
8817
2.96
139.17
12.5
6.1
%
25.9
27.7
7.46
1449
8201
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
191
249
8.25
139.07
1.3
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1538
9088
2.96
137.39
12.0
5.8
e9/l
0.0
0.0
0.15
1408
7773
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
223
351
6.91
137.26
1.6
1.5
u/ml
22.6
17.2
—
6
9
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1556
9269
2.96
136.58
11.6
6.6
mmol/l
1.2
1.2
4.82
1333
7814
(4062490)
143
130
11.64
136.19
1.8
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
211
317
7.21
135.60
1.5
1.5
u/ml
122.3
108.5
1.45
36
60
(3013115) Eosinophils [#/volume] in Blood
1563
9407
2.93
133.16
12.2
6.0
e9/l
0.2
0.2
0.10
1434
8175
(3001604) Monocytes [#/volume] in Blood
1524
9053
2.90
133.08
12.1
5.8
e9/l
0.6
0.6
1.04
1395
7727
(3003458) Phosphate [Moles/volume] in Serum or Plasma
659
2496
3.27
132.29
8.6
5.7
mmol/l
1.0
1.1
0.09
633
2309
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
757
3113
3.10
131.95
2.4
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1479
8683
2.86
131.47
12.2
5.9
%
58.6
57.3
3.88
1425
8116
(3019198) Lymphocytes [#/volume] in Blood
1548
9322
2.89
130.75
12.1
5.8
e9/l
1.7
1.9
5.66
1420
8137
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
178
231
8.25
129.98
1.1
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
723
2922
3.12
129.59
5.7
3.4
mmol/l
0.8
0.8
9.36
701
2727
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1450
8472
2.82
129.27
10.6
5.9
mmol/l
1.2
1.2
3.92
1376
7630
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
188
267
7.56
126.98
3.9
3.3
u/ml
903.8
1386.3
0.17
15
21
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
265
538
5.42
125.27
7.7
5.5
mg/l
1.6
1.5
1.20
257
497
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1310
7349
2.74
125.15
4.0
2.2
nmol/l
75.2
77.4
2.04
1223
6504
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
595
2207
3.26
122.70
1.7
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
142
155
9.68
118.78
1.3
1.2
u/l
53.9
57.4
0.21
101
107
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
975
4817
2.73
118.34
3.4
2.2
mg/l
3.2
3.0
2.15
870
4060
(3034274) Bile acid [Moles/volume] in Serum --fasting
138
149
9.77
116.35
5.9
2.3
umol/l
32.8
6.9
5.31
123
101
(3048929) Epstein Barr virus Ab [Presence] in Serum
251
533
5.15
112.43
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
93
56
17.24
112.01
1.8
4.9
—
—
—
0
0
(4035726)
446
1552
3.31
100.55
1.7
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
1015
5442
2.51
100.13
6.0
3.8
ph
7.4
7.4
0.00
238
996
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1261
7565
2.42
95.66
3.9
2.7
ug/l
148.9
134.4
0.97
1188
6928
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
152
244
6.59
91.28
7.6
6.0
mg/l
12.3
11.4
1.07
140
227
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
66
29
23.38
91.16
3.1
2.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
276
745
4.06
90.77
2.2
1.9
ug/l
2.6
2.2
0.21
254
644
(3024932) HLA-DR beta [Type]
82
58
14.61
90.65
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
82
58
14.61
90.65
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1015
5634
2.40
90.45
4.8
3.2
e6/l
128.3
80.5
0.27
864
4340
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
211
467
4.86
89.56
1.3
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
95
89
11.08
88.38
1.3
1.1
u/l
155.1
81.0
2.68
85
76
(40768797) Stomach Pathology biopsy report
555
2349
2.78
87.27
1.5
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
90
84
11.10
83.92
1.3
1.2
u/l
40.6
16.7
1.61
80
72
(3031040) Bacteria [#/volume] in Urine by Automated count
1689
11958
2.42
82.02
6.4
4.5
e6/l
566.4
2098.3
1.30
33
175
(3013005) Retinol [Moles/volume] in Serum or Plasma
75
55
14.05
81.19
5.2
1.6
umol/l
1.6
2.0
1.98
75
49
(3013707) Erythrocyte sedimentation rate by Westergren method
1814
13300
2.53
80.78
7.8
3.9
mm/h
17.7
12.5
28.30
1710
12282
(3000850) Epithelial cells [#/volume] in Urine
767
3933
2.40
79.78
3.8
2.6
e6/l
6.5
5.3
1.13
706
3427
(3018095) Leukocytes [#/volume] in Urine
1095
6545
2.25
79.05
5.6
3.7
e6/l
64.0
108.8
1.65
889
4655
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
512
2177
2.72
79.03
2.3
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
94
102
9.55
78.74
2.0
1.5
u/l
4.7
5.6
0.17
55
50
(40758558) Short blood count panel - Blood
856
4632
2.32
78.39
13.1
6.6
—
—
—
0
0
(3026782) Osmolality of Urine
728
3673
2.41
78.30
4.1
2.7
mosm/kgh2o
552.3
549.3
0.14
658
3098
(3012544) pH of Venous blood
468
1913
2.80
77.88
7.0
3.9
ph
7.4
7.4
—
5
9
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
100
120
8.65
77.49
1.4
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
457
1855
2.81
77.00
7.0
4.0
mmol/l
1.2
1.9
3.56
382
1461
(3018677) aPTT in Platelet poor plasma by Coagulation assay
616
2903
2.51
76.73
3.6
2.2
s
30.5
29.9
1.71
603
2819
(3021447) Carbon dioxide [Partial pressure] in Venous blood
455
1867
2.78
74.93
7.0
3.9
kpa
5.7
5.8
2.58
442
1813
(3030467) Casts [#/volume] in Urine by Automated count
909
5151
2.24
73.49
4.9
3.2
e6/l
0.5
0.5
0.27
764
3904
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
502
2187
2.64
73.31
2.3
1.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
99
126
8.15
73.11
1.1
1.0
mg/l
307.0
291.8
0.71
89
108
(3000991) Gas panel - Venous blood
413
1650
2.82
71.32
12.4
8.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
315
1096
3.16
69.61
1.7
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
110
169
6.78
68.73
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
499
2251
2.54
67.26
3.5
2.6
%
1.9
1.8
1.17
450
1976
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
487
2172
2.56
67.23
3.3
4.1
u/l
244.8
243.9
0.04
467
2057
(36304419) Bacteria [Presence] in Urine
875
5034
2.17
66.67
4.8
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1688
12470
2.22
66.10
6.2
4.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
110
177
6.47
65.73
2.4
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
143
300
5.01
64.38
1.6
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
92
125
7.62
64.22
1.1
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1110
7071
2.07
63.82
3.0
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
472
2133
2.51
63.01
1.5
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
916
5462
2.10
62.69
3.7
3.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
447
1978
2.55
62.34
2.3
1.8
%
1.5
1.5
0.90
384
1720
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
194
541
3.82
60.34
1.6
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1207
8052
2.01
59.72
22.9
9.4
e9/l
0.0
0.0
0.49
1045
6519
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
318
1214
2.87
59.18
11.0
8.0
mmol/l
24.4
24.8
1.24
312
1207
(3021879) Hepatitis B virus core Ab [Presence] in Serum
311
1184
2.87
58.12
1.3
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
57
47
12.40
57.45
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
57
49
11.89
55.96
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
357
1490
2.64
55.73
5.3
4.2
%
0.9
0.9
0.04
154
433
(3014111) Lactate [Moles/volume] in Serum or Plasma
383
1677
2.53
54.06
10.3
7.2
mmol/l
1.4
1.4
0.02
366
1601
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
568
2968
2.20
53.29
3.9
3.0
e6/l
2.5
2.1
0.44
362
1635
(3002179) Metamyelocytes/100 leukocytes in Blood
330
1364
2.65
52.36
5.0
4.0
%
0.6
0.6
0.07
110
318
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
272
1021
2.88
51.95
7.4
4.4
mmol/l
23.7
24.0
0.94
257
930
(3023520) Reticulocytes [#/volume] in Blood
379
1684
2.49
51.69
3.1
2.6
e9/l
71.4
68.5
0.61
293
1262
(3016502) Oxygen saturation in Arterial blood
411
1910
2.39
50.72
11.3
7.6
%
96.1
95.2
2.43
402
1830
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
295
1173
2.73
50.45
2.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
410
1918
2.37
49.77
5.0
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
441
2138
2.30
49.25
10.9
7.2
mmol/l
0.3
1.0
2.94
359
1667
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
128
306
4.36
48.99
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
380
1730
2.42
48.98
11.7
7.9
g/l
112.8
121.9
14.03
370
1661
(3022217) INR in Platelet poor plasma by Coagulation assay
499
2554
2.21
48.83
25.0
26.8
inr
1.3
1.4
1.18
89
329
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
581
3157
2.11
48.77
3.7
2.8
e6/l
1.3
1.2
0.31
373
1817
(3025941) Bacteria identified in Stool by Culture
245
902
2.91
48.38
1.5
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
330
1417
2.54
48.21
5.4
4.2
%
0.1
0.1
1.14
148
396
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
172
521
3.48
47.11
4.5
2.9
%
211.3
183.9
3.73
166
498
(3027801) Oxygen [Partial pressure] in Arterial blood
434
2149
2.25
45.80
11.0
7.2
kpa
12.5
12.1
0.86
422
2035
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1040
7018
1.86
45.63
5.2
3.7
ng/l
34.7
59.0
2.25
815
4971
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
433
2150
2.24
45.35
11.1
7.2
kpa
5.0
5.1
2.27
420
2035
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
235
876
2.87
45.27
1.7
1.8
g/l
1.5
1.5
0.11
196
754
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
32
13
24.94
45.19
3.8
3.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
250
975
2.75
44.18
13.8
10.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
309
1344
2.49
43.72
5.5
4.3
%
0.0
0.4
0.83
119
342
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
31
13
24.15
43.25
4.7
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2118
18275
2.44
41.67
44.5
14.1
mg/l
31.3
24.8
17.01
2023
14369
(3015377) Calcium [Moles/volume] in Serum or Plasma
937
6254
1.82
41.51
5.4
3.2
mmol/l
2.3
2.4
6.11
848
5419
(3036481) Cortisol [Moles/volume] in Serum or Plasma
341
1586
2.34
41.46
2.6
2.1
nmol/l
347.5
369.8
1.06
323
1450
(40760892) CBC W Ordered Manual Differential panel - Blood
648
3851
1.94
41.34
7.6
4.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
190
662
3.03
41.25
3.4
3.3
u/ml
0.3
0.3
1.20
101
375
(3014007) Fractional oxyhemoglobin in Arterial blood
274
1163
2.53
40.72
13.5
9.3
%
94.1
93.8
0.40
274
1157
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
160
525
3.20
38.45
2.0
1.7
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49
59
8.46
37.77
3.6
2.3
u/ml
816.9
3555.2
0.46
12
11
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
192
707
2.87
37.68
2.0
1.8
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
119
328
3.77
37.47
1.2
1.2
titre
94.3
72.5
—
7
8
(3007853) Bacteria identified in Skin by Aerobe culture
406
2110
2.11
37.31
2.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
203
779
2.76
36.85
2.2
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
396
2050
2.12
36.72
1.8
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
486
2725
1.98
36.16
1.9
1.8
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
111
301
3.82
35.77
3.9
3.5
%
1.0
1.5
1.03
93
233
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1069
7647
1.72
35.65
2.3
2.0
pmol/l
90.7
94.8
1.96
631
3913
(3035350) Ketones [Presence] in Urine by Test strip
1187
8741
1.71
35.57
4.9
3.6
estimate
0.0
0.0
0.00
273
1589
(3024354) Oxygen [Partial pressure] in Venous blood
323
1566
2.23
35.28
6.7
3.5
kpa
4.8
4.7
0.49
310
1514
(3009261) Glucose [Presence] in Urine by Test strip
1198
8866
1.71
35.06
5.0
3.7
estimate
0.0
0.0
0.50
272
1568
(3021601) Nitrite [Presence] in Urine by Test strip
1187
8764
1.71
35.03
6.7
4.9
estimate
0.0
0.0
0.50
281
1615
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
55
84
6.68
34.50
1.2
1.2
u/l
32.9
30.4
0.10
42
60
(3027273) Bicarbonate [Moles/volume] in Venous blood
219
907
2.56
34.08
5.3
3.2
mmol/l
24.2
25.1
3.48
212
880
(3019309) Folate [Moles/volume] in Red Blood Cells
593
3618
1.85
33.88
2.0
1.8
nmol/l
1220.2
1175.6
0.49
479
2692
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
54
83
6.63
33.67
1.2
1.2
u/l
109.0
82.0
1.05
44
61
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
300
1440
2.24
33.49
3.4
2.8
ml/min/173m2
60.7
64.1
0.66
134
586
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
39
41
9.65
33.31
2.2
2.1
mg/l
8.3
9.5
0.44
30
34
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
304
1478
2.21
32.86
5.7
3.5
mmol/l
1.2
1.2
1.04
291
1260
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
617
3856
1.81
32.38
2.5
1.8
mg/l
2.1
1.3
2.41
513
2941
(3012501) Base excess in Blood by calculation
129
413
3.25
32.25
5.3
4.4
mmol/l
2.6
2.8
0.28
92
285
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
154
548
2.94
32.11
1.8
1.5
iu/ml
0.2
11.1
0.56
44
122
(3026493) Urate [Moles/volume] in Serum or Plasma
721
4734
1.75
31.86
4.1
2.7
umol/l
3646.5
5792.4
0.79
661
4068
(3009343) pH of Capillary blood
272
1286
2.26
31.41
6.9
4.3
ph
7.4
7.4
0.18
41
146
(3003694) ABO and Rh group [Type] in Blood
732
4843
1.74
31.40
1.5
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
274
1300
2.25
31.38
6.9
4.3
kpa
4.9
5.2
4.15
250
1211
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
290
1410
2.20
31.28
5.6
4.1
ng/l
95.6
92.3
0.23
264
1220
(3036489) Thrombin time
178
697
2.68
30.98
4.3
2.4
s
22.5
21.5
1.62
168
633
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
594
3714
1.80
30.92
1.4
1.3
u/ml
1.8
2.0
0.08
140
946
(3023487) Leukocytes [#/volume] in Peritoneal fluid
45
65
7.04
29.71
2.3
2.6
e6/l
4253.2
605.5
0.61
34
53
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
261
1246
2.23
29.37
7.0
4.3
mmol/l
1.0
1.7
1.94
182
925
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
113
356
3.28
29.00
5.4
3.8
%
57.7
57.9
0.03
113
356
(3004119) Hemoglobin [Mass/volume] in Venous blood
242
1127
2.28
28.90
6.1
3.3
g/l
119.7
128.4
7.30
235
1104
(3019550) Sodium [Moles/volume] in Serum or Plasma
2117
18856
2.11
28.85
44.0
16.5
mmol/l
139.0
139.6
23.63
2099
18330
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
572
3612
1.77
28.46
4.4
3.7
ng/l
131.7
746.4
1.69
458
2915
(3023103) Potassium [Moles/volume] in Serum or Plasma
2118
18902
2.09
28.17
44.0
16.7
mmol/l
3.9
4.0
12.67
2097
18347
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
115
373
3.19
28.14
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
609
3926
1.74
28.13
1.9
1.7
pmol/l
426.8
30120910.3
3.30
515
3237
(3044007) Cell count panel - Peritoneal fluid
39
51
7.76
28.08
2.4
2.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
42
60
7.11
28.01
2.3
2.4
e6/l
9739.8
30709.4
0.35
24
38
(1616796) Gas panel - Central venous blood
121
406
3.09
27.96
4.9
3.6
—
—
—
0
0
(3010421) pH of Blood
137
494
2.88
27.87
5.3
4.1
ph
7.4
7.4
0.74
125
406
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
129
457
2.93
27.10
1.8
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
241
1150
2.22
27.09
10.1
6.5
mmol/l
23.8
24.6
2.32
227
1064
(3021960) Folate [Moles/volume] in Serum or Plasma
657
4388
1.69
26.39
1.8
1.6
nmol/l
19.7
20.5
0.68
593
3726
(3033799) Differential panel - Peritoneal fluid
39
55
7.19
26.30
2.4
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
106
343
3.19
26.04
5.2
3.4
e9/l
4.6
4.3
0.44
106
343
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
790
5557
1.63
25.80
3.2
3.2
ng/l
1628.1
1722.1
0.24
706
4754
(3013512) EKG study
754
5267
1.63
25.20
5.0
3.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
214
1006
2.24
24.90
13.9
9.6
mmol/l
23.7
24.4
2.23
205
930
(3051651) Icteric interference index of Serum or Plasma
55
115
4.87
24.84
5.9
3.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
121
440
2.84
24.23
2.0
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
904
6669
1.57
23.68
5.3
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
244
1233
2.09
23.60
6.9
4.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
140
561
2.59
23.22
7.4
5.9
mmol/l
1.3
1.3
0.07
121
486
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
168
739
2.37
22.81
7.0
5.0
%
1.6
1.6
0.02
162
686
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
534
3498
1.68
22.57
5.3
2.9
mmol/l
2.5
2.5
8.90
476
3055
(3007930) Methemoglobin/Hemoglobin.total in Blood
165
726
2.37
22.38
7.1
5.0
%
0.9
0.9
0.49
159
678
(3052851) Hemolysis interference index of Serum or Plasma
136
552
2.55
21.97
4.6
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1913
16883
1.68
21.65
35.2
13.3
ml/min/173m2
80.2
79.1
1.13
1725
13882
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1340
10930
1.52
21.31
3.3
2.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
73
213
3.50
21.17
3.5
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
196
955
2.15
20.80
7.5
4.5
—
—
—
0
0
(3019225) pH of Specimen
321
1860
1.84
20.71
5.8
4.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
186
891
2.18
20.60
5.4
2.8
%
1.2
1.2
0.13
186
884
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
95
332
2.94
20.47
1.6
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2121
19353
1.88
20.32
34.1
9.8
u/l
39.5
25.9
60.48
2088
18585
(3014148) Varicella zoster virus Ab [Titer] in Serum
67
191
3.58
20.13
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
655
4631
1.57
19.92
5.0
3.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
112
434
2.66
19.88
1.6
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
112
434
2.66
19.88
1.6
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
73
222
3.36
19.87
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
72
218
3.37
19.74
1.8
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
104
392
2.73
19.49
4.0
2.5
%
15.1
16.2
1.76
53
199
(3025468) Yersinia sp identified in Specimen by Organism specific culture
71
215
3.37
19.46
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
72
221
3.33
19.32
1.8
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
1509
12771
1.50
18.96
4.6
3.8
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
31
49
6.40
18.83
3.1
3.4
au/ml
35.7
107.5
—
5
9
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
70
215
3.32
18.77
1.8
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
269
1522
1.87
18.65
6.0
3.9
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
176
860
2.13
18.52
7.7
4.8
mmol/l
24.1
24.7
2.09
171
803
(3005988) Vibrio sp identified in Specimen by Organism specific culture
70
217
3.29
18.50
1.8
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
28
41
6.90
18.26
1.1
1.5
g/l
18.4
28.2
2.03
20
32
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
114
465
2.52
18.24
1.9
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
658
4738
1.54
18.15
5.5
4.0
estimate
0.0
0.0
1.08
263
1533
(3002385) Erythrocyte distribution width [Ratio]
1726
15086
1.52
18.01
47.8
17.2
%
14.3
13.7
37.93
1712
14724
(3009508) Creatinine [Moles/volume] in Urine
754
5643
1.49
17.11
3.8
3.2
mmol/l
7.0
7.5
2.43
648
4752
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
59
173
3.47
17.03
2.6
2.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
78
272
2.93
16.91
1.6
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
43
101
4.32
16.90
2.1
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
94
367
2.63
16.47
1.7
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
735
5519
1.48
16.23
4.6
4.0
mg/mmol
12.4
8.8
0.73
491
3502
(3015235) Bicarbonate [Moles/volume] in Capillary blood
112
479
2.40
16.21
4.6
3.3
mmol/l
23.8
24.9
1.60
96
414
(3028626) Oxygen [Partial pressure] in Capillary blood
124
555
2.30
16.19
9.1
4.5
kpa
9.1
8.5
2.92
110
522
(40761511) CBC panel - Blood by Automated count
2067
18966
1.68
16.15
36.2
13.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
263
1544
1.79
16.09
2.2
2.6
g/l
65.8
66.2
0.34
240
1404
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
43
105
4.15
16.09
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
43
106
4.11
15.89
1.7
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
141
672
2.17
15.81
3.7
3.8
g/l
0.3
0.3
0.11
89
289
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
21
26
8.14
15.77
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
84
318
2.70
15.65
1.8
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
66
219
3.07
15.63
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
118
527
2.30
15.49
1.8
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
23
33
7.03
15.26
1.6
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
36
80
4.55
15.18
4.5
2.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
36
81
4.50
14.95
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
36
81
4.50
14.95
1.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
576
4179
1.50
14.86
4.3
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
695
5247
1.46
14.62
3.8
3.2
mg/l
476.3
308.2
0.40
477
3359
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
70
250
2.85
14.58
1.5
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
27
49
5.56
14.31
1.6
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
93
395
2.41
13.70
9.3
6.6
mmol/l
11.2
11.4
0.13
87
349
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
36
87
4.19
13.68
1.2
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
93
396
2.40
13.63
9.3
6.6
mmol/l
106.2
105.3
1.09
87
350
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
73
277
2.69
13.58
1.8
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
62
216
2.92
13.52
1.7
1.7
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
27
52
5.24
13.43
1.6
1.6
g/l
8.8
14.2
3.29
20
45
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
29
6.95
13.14
2.1
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
82
337
2.48
12.99
2.7
1.8
nmol/l
0.7
0.8
0.50
71
287
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
724
5610
1.42
12.91
2.4
2.1
u/l
221.1
238.0
0.14
684
5268
(3051611) Lipemic interference index of Serum or Plasma
58
201
2.93
12.79
6.0
3.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
56
191
2.98
12.70
4.0
3.5
%
66.7
57.5
2.34
39
127
(3024891) Influenza virus A+B Ag [Presence] in Specimen
108
507
2.18
12.62
1.4
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
39
107
3.69
12.49
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
65
244
2.71
12.37
1.7
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
108
3.65
12.32
1.1
1.2
—
—
—
0
0
(44790048)
60
221
2.76
11.85
2.1
1.5
—
—
—
0
0
(44806118)
60
221
2.76
11.85
2.1
1.5
—
—
—
0
0
(44790049)
60
221
2.76
11.85
2.1
1.5
—
—
—
0
0
(44790047)
60
221
2.76
11.85
2.1
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
106
512
2.12
11.54
1.3
1.1
—
—
—
0
0
(3020891) Body temperature
142
763
1.92
11.50
8.1
4.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
210
1271
1.72
11.49
1.7
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
107
522
2.10
11.36
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
106
516
2.10
11.32
1.3
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
22
42
5.28
11.06
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
52
185
2.85
10.98
1.3
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
55
202
2.76
10.95
1.3
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
25
54
4.67
10.94
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
48
165
2.95
10.78
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
77
336
2.33
10.74
4.9
2.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
47
4.93
10.73
1.0
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
124
652
1.95
10.72
2.4
2.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
59
228
2.63
10.66
3.4
2.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
168
2.90
10.45
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
168
2.90
10.45
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
168
2.90
10.45
1.3
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
255
1672
1.59
10.18
2.9
2.9
ng/l
219.2
228.5
0.13
240
1513
(3009542) Hematocrit [Volume Fraction] of Blood
1821
16695
1.39
10.04
39.9
15.4
%
37.3
39.7
19.61
1275
11757
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
38
120
3.20
9.87
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
192
1182
1.68
9.86
3.6
2.8
e9/l
4.3
4.1
0.44
143
920
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
25
59
4.27
9.84
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
55
214
2.61
9.82
1.5
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
23
51
4.54
9.77
1.9
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
34
101
3.40
9.73
2.9
2.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
99
501
2.02
9.57
1.6
1.7
—
—
—
0
0
(3019977) pH of Arterial blood
31
88
3.56
9.50
2.9
3.1
ph
7.4
7.4
0.07
13
25
(3006184) Hemoglobin [Mass/volume] in Capillary blood
84
404
2.12
9.31
3.8
2.2
g/l
119.1
129.7
3.49
66
297
(3011412) CD3 cells [#/volume] in Blood
45
163
2.79
9.24
1.7
2.6
e9/l
1.0
1.1
0.59
26
92
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
25
63
4.00
9.05
1.2
2.0
umol/l
47.2
91.0
—
10
41
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
66
294
2.28
8.84
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
248
1670
1.54
8.80
2.5
2.4
ug/l
4.8
7.4
2.35
209
1454
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
63
277
2.31
8.70
1.1
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
35
115
3.07
8.55
1.8
2.5
—
—
—
0
0
(4281824)
47
182
2.61
8.52
1.1
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
59
256
2.34
8.41
1.1
1.1
iu/ml
224.4
144.3
—
7
54
(3004451) EKG impression Narrative
28
81
3.49
8.37
1.6
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
126
726
1.78
8.23
1.7
1.8
u/l
39.2
38.9
0.06
112
640
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
85
431
2.01
8.21
1.2
1.3
miu/ml
222.0
226.8
0.03
24
185
(3043409) Potassium [Moles/volume] in Arterial blood
104
567
1.87
8.13
6.8
3.8
mmol/l
3.8
3.9
0.40
95
527
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
30
93
3.25
8.07
1.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
30
93
3.25
8.07
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
30
93
3.25
8.07
1.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
30
93
3.25
8.07
1.1
1.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
138
823
1.72
8.00
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2140
20378
1.50
7.97
57.4
20.7
e9/l
7.2
6.7
6.34
2106
19711
(3007461) Platelets [#/volume] in Blood
2138
20363
1.49
7.87
57.5
20.7
e9/l
250.4
247.1
1.09
2112
19762
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
35
121
2.92
7.86
1.5
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
47
190
2.50
7.83
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
27
80
3.40
7.80
2.4
2.9
u/ml
2650.0
1115.7
0.68
27
80
(3024731) MCV [Entitic volume]
2138
20370
1.49
7.79
57.2
20.6
fl
90.9
91.1
0.55
2119
20008
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
39
144
2.74
7.77
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
75
371
2.05
7.77
1.2
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
2138
20372
1.48
7.76
57.1
20.6
pg
30.1
30.3
5.08
2118
20008
(3026361) Erythrocytes [#/volume] in Blood
2138
20373
1.48
7.75
57.4
20.7
e12/l
4.3
4.5
47.13
2103
19710
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
86
448
1.95
7.72
1.2
1.1
u/ml
5.8
7.1
—
8
49
(3000963) Hemoglobin [Mass/volume] in Blood
2138
20378
1.48
7.68
57.9
20.8
g/l
127.4
135.1
84.55
2117
20021
(3022493) Free Hemoglobin [Mass/volume] in Plasma
26
76
3.45
7.67
1.7
4.5
mg/l
70.1
77.3
0.20
18
57
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
65
306
2.16
7.66
5.6
2.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
40
151
2.68
7.65
1.8
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
18
6.70
7.61
1.0
1.3
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
11
15
7.36
7.55
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
36
132
2.75
7.29
1.3
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
78
403
1.97
7.19
2.9
2.4
ug/min
127.1
76.9
0.36
50
252
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
30
101
3.00
7.08
1.5
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
19
47
4.07
7.08
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
30
102
2.97
6.96
1.5
1.6
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
102
584
1.78
6.86
1.3
1.2
u/ml
0.3
0.9
—
7
48
(3019150) Specific gravity of Urine by Refractometry
485
3879
1.31
6.38
5.3
4.0
kg/l
1.0
1.0
0.68
92
585
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
21
61
3.46
6.28
1.1
1.1
miu/ml
1368.2
1515.4
0.27
21
61
(1761482) Bacteria [#/volume] in Urine by Culture
85
474
1.82
6.26
7.2
4.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
23
72
3.22
6.14
1.2
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
23
72
3.22
6.14
1.2
1.9
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
12
23
5.24
6.01
3.8
2.7
—
10.8
—
0
5
(3003181) Sodium [Moles/volume] in Urine
67
353
1.92
5.90
1.9
1.4
mmol/l
54.9
64.5
1.05
50
280
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
23
74
3.13
5.89
1.2
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
38
160
2.40
5.88
1.4
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
80
448
1.81
5.84
1.9
2.0
mg/l
12.6
11.2
0.67
73
414
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
32
125
2.58
5.79
1.8
2.8
e6/l
429.3
553.3
0.59
26
108
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
109
669
1.66
5.76
2.1
2.3
ug/l
289.2
814.9
1.00
102
624
(36660697) Celiac disease serology panel - Serum
191
1335
1.47
5.69
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
77
430
1.82
5.68
1.6
3.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
31
121
2.58
5.63
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
31
121
2.58
5.63
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
31
121
2.58
5.63
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
32
127
2.54
5.62
1.9
2.6
%
11.9
12.9
0.13
15
65
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
31
123
2.54
5.46
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
31
123
2.54
5.46
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
31
123
2.54
5.46
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
38
3.97
5.44
2.5
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
43
3.74
5.36
1.5
1.8
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
24
85
2.84
5.25
1.5
1.8
u/field
0.9
4.4
1.02
17
63
(3003338) MCHC [Mass/volume]
1657
15467
1.23
5.18
49.0
18.2
g/l
330.6
332.5
13.43
1645
15317
(40761535) Cells panel - Urine sediment
214
1562
1.41
5.06
4.5
3.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
95
585
1.65
5.00
1.7
3.2
mg/l
47.7
48.5
0.06
69
474
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
41
3.68
4.92
1.5
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
14
37
3.80
4.81
1.6
1.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
56
300
1.89
4.76
1.2
1.2
u/l
55.9
38.9
0.30
50
254
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
94
586
1.63
4.73
1.7
3.2
mg/l
37.7
75.4
0.95
66
477
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
657
1.59
4.72
1.9
2.5
g/l
11.9
10.3
2.26
86
562
(3016750) Collection duration of Urine
24
91
2.65
4.65
2.8
2.3
min
505.7
507.4
0.03
18
62
(3051387) C reactive protein [Mass/volume] in Capillary blood
71
414
1.74
4.59
4.7
3.4
mg/l
31.6
27.1
0.48
44
265
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
8
8
10.03
4.52
1.3
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
40
194
2.08
4.50
1.3
1.3
pmol/l
394.9
275.1
0.36
31
153
(21494755) Public health laboratory ask at order entry panel
94
1443
0.64
4.45
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
76
2.78
4.45
1.1
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
35
3.73
4.36
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
30
131
2.31
4.36
1.1
1.1
—
—
—
0
0
(4211845)
22
83
2.67
4.32
3.5
3.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
166
1196
1.42
4.26
3.7
3.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
284
2229
1.31
4.23
4.4
4.5
%
33.2
32.8
0.23
225
1465
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
16
51
3.15
4.21
1.3
1.2
ug/l
10.2
9.6
0.20
16
51
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1862
17731
1.23
4.16
5.5
4.3
mmol/l
4.4
4.6
14.73
1736
16289
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
711
1.53
4.15
1.9
2.4
g/l
7.5
7.4
0.17
71
537
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
711
1.53
4.15
1.9
2.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
57
3.00
4.12
1.4
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
57
323
1.78
4.10
1.4
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
52
3.09
4.08
1.1
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
10
8.02
4.06
1.0
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
45
238
1.91
4.02
1.8
2.2
mg/l
35.9
23.3
0.50
11
59
(40768446) Kidney Pathology biopsy report
19
69
2.77
4.02
1.8
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
100
1477
0.66
3.97
1.6
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
711
1.51
3.95
1.9
2.4
g/l
4.1
3.8
1.24
69
507
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
118
2.30
3.94
1.6
1.3
mmol/l
12.7
11.4
0.41
16
29
(40768443) Skin Pathology biopsy report
110
745
1.50
3.92
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
60
991
0.60
3.91
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
28
125
2.25
3.90
1.6
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
20
76
2.65
3.90
2.9
3.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
130
912
1.45
3.88
5.6
3.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
33
159
2.09
3.82
8.6
4.5
%
9.8
11.5
1.41
33
159
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1457
13607
1.18
3.81
4.1
3.8
pmol/l
14.8
14.9
0.37
1330
12245
(3004775) Volume in Urine collected for unspecified duration
27
120
2.26
3.80
2.8
2.4
ml
826.5
651.8
1.00
19
73
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
8
8.77
3.77
1.0
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
67
412
1.64
3.64
1.3
1.2
u/ml
6.4
10.6
—
6
64
(3001964) Herpes simplex virus Ag [Presence] in Specimen
16
56
2.87
3.63
1.4
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
65
397
1.66
3.62
8.5
3.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
51
2.95
3.57
2.1
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
51
2.95
3.57
2.1
2.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
47
263
1.80
3.57
2.7
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1734
16477
1.19
3.56
4.9
4.6
mu/l
2.0
2.2
0.52
1602
14956
(3008536) Aspergillus sp Ab [Presence] in Serum
13
41
3.18
3.49
1.2
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
68
425
1.62
3.48
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
40
215
1.88
3.45
1.1
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
39
208
1.89
3.44
1.3
1.3
mu/l
168.6
58.0
0.59
34
180
(3044927) Protein electrophoresis panel - Urine
38
201
1.90
3.44
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
23
100
2.31
3.43
1.3
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
47
2.99
3.41
1.1
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
48
277
1.75
3.31
1.4
1.4
g/l
30.4
31.3
0.19
42
250
(3028308) Erythrocytes [#/volume] in Pleural fluid
41
226
1.83
3.29
1.2
1.4
e6/l
28002.2
87232.2
1.03
26
133
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
536
4660
1.19
3.18
1.9
1.6
mmol/l
1.4
1.4
0.01
472
3916
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
29
144
2.03
3.15
2.1
2.1
u/field
1.2
2.3
0.86
11
54
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1741
16611
1.18
3.15
7.6
5.6
mmol/mol
41.5
39.9
7.01
1622
15240
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
19
79
2.42
3.13
1.4
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
43
246
1.76
3.08
1.3
1.4
e6/l
3007.0
1752.9
0.30
32
175
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
341
2857
1.23
2.96
1.5
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
94
2.25
2.96
5.7
14.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
38
214
1.79
2.88
1.3
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
9
6.68
2.87
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
129
958
1.37
2.86
2.5
2.4
—
—
—
0
0
(4268621)
32
171
1.88
2.86
2.4
2.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
31
3.24
2.77
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
60
388
1.56
2.73
2.0
2.3
u/l
1262.0
4512.6
1.38
15
158
(1761868) Lipid panel - Serum or Plasma
536
6051
0.85
2.69
3.5
2.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1769
16978
1.16
2.66
4.7
3.9
mmol/l
1.3
1.3
1.43
1628
15367
(1002224) Polysomnography panel
42
682
0.61
2.65
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
21
99
2.13
2.64
3.0
2.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
14
55
2.55
2.61
1.1
1.1
%
78.3
89.0
—
7
29
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
14
55
2.55
2.61
1.1
1.4
%
66.9
84.3
—
7
30
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
128
1.96
2.55
1.6
1.3
promille
0.9
1.3
0.57
17
99
(3045424) Erythrocytes [Presence] in Urine
48
300
1.61
2.54
1.5
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
62
2.43
2.54
1.6
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
33
3.04
2.52
3.6
5.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
32
180
1.79
2.47
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
36
210
1.73
2.47
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
39
233
1.69
2.46
1.2
1.1
u/ml
3.3
3.0
0.09
14
98
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
71
491
1.46
2.40
1.8
2.5
g/l
0.0
0.0
0.00
66
454
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
90
2.12
2.38
3.4
4.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
28
153
1.84
2.38
2.7
3.2
mg/l
19.4
22.2
0.12
17
123
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
58
2.42
2.37
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
40
244
1.65
2.35
3.1
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
131
1010
1.31
2.32
2.9
3.2
pmol/l
4.2
4.5
3.00
114
890
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
71
495
1.45
2.31
1.8
2.5
g/l
0.0
0.0
0.00
66
455
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
659
1.38
2.24
2.0
2.4
g/l
3.3
3.1
0.82
69
518
(3002619) Bacteria identified in Specimen by Culture
9
29
3.11
2.22
1.1
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
9
5.56
2.21
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
74
526
1.42
2.19
1.8
2.5
g/l
0.1
0.0
0.47
69
483
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
24
3.34
2.18
1.6
1.5
ng/l
129.8
88.7
—
8
24
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
197
1.68
2.12
1.3
1.6
%
67.9
62.9
0.31
17
127
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
37
2.71
2.10
1.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
56
2.33
2.04
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
76
551
1.39
2.03
1.8
2.4
g/l
37.1
37.3
0.13
66
474
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
12
50
2.41
2.02
1.4
1.2
ug/l
1.5
63.6
—
7
23
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
57
2.29
1.97
1.4
2.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
31
186
1.68
1.97
1.8
2.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
82
606
1.37
1.96
1.8
2.5
g/l
0.4
1.3
2.95
73
527
(3009214) Lutropin [Units/volume] in Serum or Plasma
66
470
1.42
1.96
1.3
1.5
u/l
8.7
8.2
0.08
52
370
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
21
3.34
1.96
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
335
3832
0.85
1.96
2.7
3.1
ug/l
0.8
0.8
0.05
212
2536
(3017569) Oxygen content in Arterial blood
17
84
2.03
1.95
3.6
2.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24
134
1.80
1.95
1.6
2.4
e6/l
554.4
717.2
0.60
13
56
(3035320) C reactive protein [Mass/volume] in Body fluid
24
134
1.80
1.95
3.7
2.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
164
1.72
1.94
1.3
1.4
%
31.2
29.4
0.09
16
101
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
44
290
1.53
1.93
2.0
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
22
3.19
1.88
1.9
1.8
—
—
—
0
0
(4015189)
12
52
2.31
1.87
1.4
2.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
136
1.77
1.87
1.7
2.3
mmol/l
7.6
7.0
0.54
19
87
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
40
2.51
1.83
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
21
116
1.82
1.78
1.2
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
60
2.17
1.77
3.0
2.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
200
1.61
1.77
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
79
592
1.35
1.76
1.6
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
13
3.85
1.71
1.8
2.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
219
1.56
1.68
1.4
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
12
55
2.19
1.67
2.7
3.1
e6/l
100.0
317.4
—
5
31
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
57
409
1.40
1.67
1.4
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
188
1.60
1.66
1.1
1.3
nmol/l
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
25
2.81
1.65
11.7
8.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
71
532
1.34
1.61
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
43
2.33
1.60
1.7
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
101
797
1.28
1.59
2.0
1.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
57
414
1.39
1.57
1.8
1.7
e6/l
12470.2
15182.8
0.28
39
295
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
33
2.43
1.53
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
27
2.60
1.51
2.9
2.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
21
2.86
1.50
1.0
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
43
606
0.70
1.49
1.4
1.7
mg/l
3.0
3.1
0.09
37
420
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1807
17593
1.11
1.45
5.2
4.3
mmol/l
1.4
1.5
4.11
1667
16058
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
28
2.50
1.45
2.9
2.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
40
2.25
1.40
1.1
1.1
%
95.7
86.7
—
9
40
(40768800) Prostate Pathology biopsy report
27
409
0.66
1.38
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1856
18116
1.11
1.36
5.5
4.8
mmol/l
2.5
2.7
21.26
1708
16552
(3012441) Differential panel - Pleural fluid
32
215
1.50
1.35
1.3
1.4
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
38
0.00
1.34
0.0
1.1
—
17.9
—
0
29
(3043410) Blood group antigens tested for on Red Blood Cells
11
54
2.04
1.32
1.9
2.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
30
201
1.50
1.30
1.2
1.4
mosm/kgh2o
280.0
278.6
0.08
22
147
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
414
0.67
1.29
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
152
1786
0.84
1.29
1.6
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
69
1.89
1.28
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
43
310
1.39
1.28
1.7
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
66
509
1.31
1.28
1.8
1.6
mu/l
364.9
306.6
0.67
61
466
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
44
2.05
1.26
1.7
3.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
25
2.40
1.24
1.5
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1795
17520
1.10
1.23
5.2
4.5
mmol/l
6.2
5.9
7.98
1654
15792
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
31
213
1.46
1.20
1.2
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
2.3
—
17.8
—
0
33
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
250
1.41
1.12
1.4
1.2
u/ml
4.0
5.0
0.30
23
115
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
17
103
1.66
1.12
1.6
2.8
%
35.6
37.5
—
9
31
(3045788) Cell count panel - Pleural fluid
29
202
1.44
1.07
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
602
0.76
1.07
2.4
1.9
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
52
1.93
1.06
1.0
1.0
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
7
33
2.12
1.05
1.3
1.3
ug/l
0.4
0.3
—
7
17
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
19
121
1.57
1.05
1.1
1.3
mmol/l
2.1
2.0
0.08
19
116
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
46
1.96
1.03
10.7
6.0
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
5
22
2.28
1.03
1.0
1.2
—
629.3
—
0
7
(3003740) Influenza virus B Ag [Presence] in Specimen
37
272
1.37
1.03
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
37
272
1.37
1.03
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
35
255
1.38
1.02
1.4
1.2
u/ml
2.4
3.1
0.25
17
86
(3022689) Creatine [Moles/volume] in Urine
9
48
1.88
1.00
1.3
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
99
1.62
1.00
2.6
2.4
—
—
—
0
0
(4024509)
25
172
1.46
1.00
1.4
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
76
1.71
0.99
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
71
576
1.24
0.98
2.0
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
26
182
1.43
0.96
1.4
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
26
364
0.71
0.95
1.4
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
97
816
1.20
0.94
1.0
1.1
—
—
—
0
0
(4146454)
26
184
1.42
0.91
2.0
2.7
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
6
28
2.15
0.91
2.5
2.4
—
2.5
—
0
8
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
195
0.61
0.90
1.8
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
58
465
1.25
0.90
1.4
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
29
2.07
0.89
1.2
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
10
57
1.76
0.83
1.2
1.2
g/l
34.0
38.0
—
5
30
(44813793)
6
114
0.53
0.82
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
63
764
0.82
0.82
2.3
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
97
1.55
0.81
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
89
756
1.18
0.81
2.6
2.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
31
232
1.34
0.81
1.3
1.1
%
119.2
115.1
0.19
24
213
(3028707) Methadone [Presence] in Urine by Screen method
18
260
0.69
0.81
2.1
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
276
1.31
0.80
1.6
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
36.8
—
0
28
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
501
5304
0.93
0.76
4.1
4.3
%
22.7
21.8
0.60
235
2589
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
24
2.09
0.74
6.8
15.6
mmol/l
5.0
6.7
—
5
24
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
236
1.32
0.74
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
219
0.68
0.73
1.5
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
25
2.00
0.72
2.6
3.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
92
1.52
0.72
1.4
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
40
1.75
0.71
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
57
472
1.21
0.70
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
101
1.49
0.70
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
41
1.71
0.70
11.7
6.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
61
1.64
0.68
1.0
1.0
—
—
—
0
0
(4034850)
71
603
1.18
0.68
15.9
10.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
102
1.47
0.67
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
249
1.29
0.67
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
43
1.63
0.66
1.7
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
169
1531
1.11
0.65
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
52
431
1.21
0.65
4.0
3.1
nmol/l
0.8
0.8
0.19
38
327
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.8
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
212
0.71
0.63
1.5
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
32
252
1.27
0.62
1.1
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
13
188
0.69
0.62
1.1
1.1
u/ml
0.2
0.4
—
5
59
(3005033) Fetal Nuchal fold Thickness US
15
211
0.71
0.62
1.5
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
63
1.59
0.61
1.1
1.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
30
1.67
0.61
3.0
6.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
9.4
—
0
15
(3048879) Bone marrow aspiration report
8
51
1.57
0.60
1.1
1.9
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
20
148
1.35
0.59
1.6
1.9
—
1.6
—
0
6
(3044941) Cell count panel - Synovial fluid
35
281
1.25
0.59
1.8
1.4
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
1.3
—
0
15
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
33.0
—
0
6
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
55
465
1.19
0.58
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
35
1.72
0.57
1.2
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
50
593
0.84
0.57
1.7
2.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
228
0.74
0.54
1.1
1.1
u/ml
2.0
4.6
—
8
96
(3005322) IgE [Units/volume] in Serum or Plasma
115
1033
1.12
0.54
1.3
1.3
u/ml
163.5
223.9
0.85
105
954
(3000492) Spirometry study
182
1675
1.09
0.54
1.5
1.5
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
9
60
1.50
0.54
1.0
1.2
%
62.4
57.3
—
9
50
(3028300) Cannabinoids [Presence] in Urine
51
600
0.85
0.54
1.7
2.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
39
1.54
0.53
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
65
748
0.87
0.53
1.8
1.7
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
204
0.73
0.53
1.1
1.1
u/ml
10.3
6.4
—
8
92
(3027008) Opiates [Presence] in Urine
51
598
0.85
0.52
1.7
2.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
19
143
1.33
0.52
1.1
1.1
—
72.1
—
0
7
(3023323) Follitropin [Units/volume] in Serum or Plasma
68
593
1.15
0.51
1.3
1.4
iu/l
27.8
27.1
0.05
53
487
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
116
1049
1.11
0.50
1.2
1.2
iu/ml
119.8
153.3
0.31
28
375
(3010726) Horse dander IgE Ab [Units/volume] in Serum
21
268
0.78
0.49
1.0
1.1
u/ml
0.7
2.8
—
6
78
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
23
182
1.27
0.46
1.0
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
297
2809
1.07
0.46
1.3
1.2
iu/ml
47.9
34.2
0.49
87
886
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
119
0.67
0.45
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
48
557
0.86
0.45
1.8
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(4306422)
29
237
1.23
0.45
1.3
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
51
588
0.86
0.45
1.7
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
86
1.40
0.44
1.3
1.7
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
17
130
1.31
0.44
1.1
1.1
—
5.6
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
18
139
1.30
0.43
1.1
1.1
—
43.8
—
0
12
(3045462) Protein/Creatinine [Ratio] in Urine
5
31
1.61
0.43
5.8
8.7
g/mol
45.8
94.5
—
5
25
(3001686) Cold agglutinin [Titer] in Serum or Plasma
5
31
1.61
0.43
1.2
1.2
—
216.4
—
0
5
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
316
0.82
0.41
1.1
1.1
u/ml
5.2
1.9
0.29
11
143
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
96
1.36
0.41
1.0
1.2
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.1
—
0
8
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
9
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.2
—
88.9
—
0
17
(3015183) Erythrocyte sedimentation rate
11
79
1.39
0.40
1.2
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(4094501)
42
485
0.86
0.39
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
258
0.81
0.38
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
258
0.81
0.38
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
118
1088
1.09
0.38
1.1
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
257
0.82
0.37
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
257
0.82
0.37
1.5
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
79
0.63
0.35
1.0
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
99
1.31
0.35
1.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
80
0.62
0.35
3.4
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
208
1.20
0.35
4.0
3.9
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
16
126
1.27
0.35
2.3
1.5
—
71.1
—
0
15
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
44
1.36
0.34
1.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
23
276
0.83
0.34
1.6
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
91
1.32
0.33
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
166
0.78
0.33
2.0
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
42
477
0.88
0.33
1.5
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
89
0.67
0.33
1.0
6.0
—
61.0
—
0
23
(40768795) Lymph node Pathology biopsy report
21
173
1.22
0.33
1.4
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
74
1.35
0.32
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
147
1565
0.94
0.32
2.1
2.0
—
—
—
0
0
(4027681)
7
97
0.72
0.31
1.3
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
32
277
1.16
0.30
1.1
1.1
—
12.2
—
0
15
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
132
1405
0.94
0.29
2.0
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
271
0.85
0.29
1.0
1.1
u/ml
0.9
1.6
—
10
134
(3019832) Treponema pallidum Ab [Presence] in Serum
117
1250
0.93
0.29
1.9
1.6
—
—
—
0
0
(4010399)
134
1260
1.07
0.29
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
228
2180
1.05
0.28
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
112
1.25
0.28
2.5
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
112
1.25
0.28
2.5
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
39
350
1.12
0.24
1.1
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
42
464
0.90
0.23
1.6
2.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
5
38
1.32
0.23
1.0
1.9
nmol/l
0.1
0.1
—
5
31
(40757494) Bilirubin.total [Moles/volume] in Blood
13
106
1.23
0.23
3.3
2.4
—
56.0
—
0
10
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
7
91
0.77
0.22
10.0
11.0
mmol/l
0.6
0.6
—
7
84
(3023511) Choriogonadotropin [Units/volume] in Urine
24
210
1.14
0.21
1.2
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
19.8
—
0
10
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
2.6
—
0
6
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
98
1.23
0.21
2.0
1.6
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.2
1.2
nmol/l
45.7
33.9
—
5
33
(3016018) Differential panel - Cerebral spinal fluid
20
173
1.16
0.21
1.1
1.9
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
9.1
—
—
—
0
0
(3024316) Viscosity of Plasma
0
13
0.00
0.21
0.0
1.3
—
1.6
—
0
8
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(44806420)
6
52
1.15
0.19
2.0
2.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
278
0.90
0.17
1.0
1.1
u/ml
3.7
4.9
0.23
13
157
(3025130) Human papilloma virus identified in Specimen
17
148
1.15
0.17
1.8
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
78
1.15
0.15
1.4
2.4
ug/l
15.5
124.6
—
9
67
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
28
255
1.10
0.15
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
43
401
1.07
0.14
1.8
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
34
367
0.93
0.14
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
122
1177
1.04
0.13
2.4
2.4
au/ml
29.4
25.0
—
6
63
(3032773) Endomysium IgG Ab [Titer] in Serum
17
151
1.13
0.13
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
43
404
1.07
0.12
1.3
1.9
iu/l
2.3
5.0
3.11
11
134
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
17
152
1.12
0.12
1.2
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
275
2700
1.02
0.11
1.3
1.2
u/ml
5.6
11.6
1.32
92
1051
(42870560) Thyrotropin [Units/volume] in Cord blood
5
61
0.82
0.08
1.0
1.0
mu/l
11.5
9.0
—
5
44
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
185
1.08
0.08
1.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
66
1.06
0.08
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
66
1.06
0.08
1.1
2.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
73
0.82
0.07
1.3
1.4
—
—
—
0
0
(4198724)
6
74
0.81
0.07
2.2
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
8
94
0.85
0.06
1.4
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
20
187
1.07
0.06
1.3
2.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
225
2275
0.99
0.05
14.6
7.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
30
313
0.96
0.05
1.3
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
666
6626
1.01
0.05
4.4
5.0
ug/l
2.7
3.8
0.76
585
5912
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
199
1.06
0.04
1.1
1.3
mmol/l
7.3
7.4
0.08
15
142
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
160
0.94
0.04
1.3
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
39
378
1.03
0.04
1.2
1.7
e6/l
18.6
27.7
0.21
27
300
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
39
378
1.03
0.04
1.2
1.8
e6/l
89.1
546.9
1.52
31
311
(3017446) Testosterone [Moles/volume] in Serum or Plasma
142
1437
0.99
0.03
2.0
2.2
nmol/l
14.5
12.7
1.87
117
1272
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
108
0.93
0.03
2.8
1.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
158
0.95
0.02
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
23
222
1.04
0.02
1.4
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
137
0.95
0.01
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
173
1.04
0.01
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
43
423
1.02
0.01
2.4
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
114
1.05
0.00
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
101
0.99
0.00
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
38
381
1.00
0.00
1.2
1.5
mmol/l
3.8
3.7
0.29
38
359
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
43
429
1.00
0.00
1.4
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
184
0.98
0.00
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
246
1.02
0.00
1.4
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
43
426
1.01
0.00
1.2
1.6
mg/l
485.6
498.1
0.10
43
403
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
2.4
—
0
9
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
78
0.90
0.00
1.0
1.2
%
—
74.7
—
0
9
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
89
0.90
0.00
1.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
82
0.98
0.00
1.3
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
92
0.98
0.00
1.0
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
59
1.02
0.00
1.3
1.9
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
94
0.96
0.00
9.4
6.6
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
12.7
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint K11_CHOLANGI and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CHOLANGI | 2.458 [2.14, 2.83] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.054 |
During the follow-up period (1.1.1998 — 31.12.2019), 2720 out of 6016 females with K11_CHOLANGI died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CHOLANGI | 2.52 [2.17, 2.93] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 2735 out of 5897 males with K11_CHOLANGI died.
Mortality risk
Mortality risk for people of age
years, who have K11_CHOLANGI.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.165% | 0.495% |
| 5 | 1.088% | 2.92% |
| 10 | 3.025% | 7.448% |
| 15 | 5.777% | 13.209% |
| 20 | 9.879% | 21.994% |
Relationships between endpoints
↥Index endpoint: K11_CHOLANGI – Cholangitis (primary sclerosing, PSC)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data